Lalwani Narendra D. 4
4 · Esperion Therapeutics, Inc. · Filed Nov 30, 2018
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-28+8,000→ 8,000 totalExercise: $52.38Exp: 2028-11-28→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on February 28, 2019.